Dear Colleague,

As a registrant who has signed up to receive Content Alerts to PLoS Clinical Trials, I hope you will be pleased to know that thousands of your colleagues have joined you in the few months since the journalís announcement. We welcome those of you who have recently signed up!

By registering for alerts, you have already recognized the value of accessing and reading PLoS Clinical Trials. Have you also considered the value of submitting a manuscript to the journal? The benefits to authors of publishing in PLoS Clinical Trials include:

  • Open access: you get the widest global audience for your work
  • You retain copyright
  • Fast, rigorous peer review by statisticians and specialist clinicians
  • All randomized trials considered, irrespective of scope and outcome
  • Fast online publication
  • All articles listed in PubMed and cross-linked to trial registry records
  • All articles permanently archived in PubMed Central

Submissions are invited in all fields of healthcare, including main trial reports as well as interim analyses, planned secondary analyses, and follow-up studies. The journal will be launching in Spring 2006.

Please contact me at to discuss the suitability of your manuscript, and visit the PLoS Clinical Trials homepage for more information about how to submit.


Emma Veitch, PhD
Publications Manager, PLoS Clinical Trials

Public Library of Science
7 Portugal Place, Cambridge